Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Screening and verification of new targets for CAR-T immunotherapy in cancer. | Front Immunol | 2023 | 37114061 | PubTator, text mining | PubMed |
| T Cell Based Immunotherapy for Cancer: Approaches and Strategies. | Vaccines (Basel) | 2023 | 37112747 | PubTator, text mining | PubMed |
| Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models. | Int J Mol Sci | 2023 | 37108788 | PubTator, text mining | PubMed |
| Combination Therapy of Radiation and Hyperthermia, Focusing on the Synergistic Anti-Cancer Effects and Research Trends. | Antioxidants (Basel) | 2023 | 37107299 | PubTator, text mining | PubMed |
| Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML. | Leukemia | 2023 | 37106163 | PubTator, text mining | PubMed |
| Mapping the functional interactions at the tumor-immune checkpoint interface. | Commun Biol | 2023 | 37106127 | PubTator, text mining | PubMed |
| Organ-based clues for diagnosis of inborn errors of immunity: A practical guide for clinicians. | Immun Inflamm Dis | 2023 | 37102642 | PubTator, text mining | PubMed |
| An eleven-gene risk model associated with lymph node metastasis predicts overall survival in lung adenocarcinoma. | Sci Rep | 2023 | 37100777 | PubTator, text mining | PubMed |
| Intracellular Adhesion Molecule-1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8+ T Cells. | Adv Sci (Weinh) | 2023 | 37097643 | PubTator, text mining | PubMed |
| Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models. | EJNMMI Radiopharm Chem | 2023 | 37093350 | PubTator, text mining | PubMed |
| Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patients. | Front Endocrinol (Lausanne) | 2023 | 37091853 | PubTator, text mining | PubMed |
| Advances in research on immune escape mechanism of glioma. | CNS Neurosci Ther | 2023 | 37088950 | PubTator, text mining | PubMed |
| Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse model. | Commun Biol | 2023 | 37087494 | PubTator, text mining | PubMed |
| The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022. | J Transl Med | 2023 | 37087493 | PubTator, text mining | PubMed |
| Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment. | Front Pharmacol | 2023 | 37077811 | PubTator, text mining | PubMed |
| Construction and evaluation of an aging-associated genes-based model for pancreatic adenocarcinoma prognosis and therapies. | Int J Immunopathol Pharmacol | 2023 | 37072128 | PubTator, text mining | PubMed |
| Hypoxia-Inducible Factor-2α Signaling in the Skeletal System. | JBMR Plus | 2023 | 37065626 | PubTator, text mining | PubMed |
| Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis. | Front Oncol | 2023 | 37064125 | PubTator, text mining | PubMed |
| Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. | Front Oncol | 2023 | 37064113 | PubTator, text mining | PubMed |
| Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy. | Front Med (Lausanne) | 2023 | 37064017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=38